The association between baseline patient characteristics and alpelisib-induced hyperglycaemia in patients with HR+, HER2-, PIK3CA-mutated metastatic breast cancer. Tolerability and effectiveness of ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to ...
Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, indicating non-mutational epigenetic reprogramming rather than canonical oncogenic ...
"Among the patients with matched samples from breast primary and metastatic sites in this study, there was a significant level of discordance in HER2 expression." — Megan Kruse, MD A team from the ...
Optimal management recommendations for patients with HER2 low breast cancer are unclear/unknown. Patients with HER2-low tumors in the new study accounted for more than half of all early breast cancer ...
Effect of high MMP2 and low MMP9 baseline serum levels on outcome in patients with HER2-positive inflammatory breast cancer (IBC) treated with bevacizumab (BEV)- and trastuzumab (TRA)-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results